Skip to main content
MRK logo

Merck & Co Inc

Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - General

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.

Did you know?

A mega-cap stock valued at $284B.

Current Price

$114.62

+1.53%

GoodMoat Value

$189.57

65.4% undervalued
Profile
Valuation (TTM)
Market Cap$284.49B
P/E15.59
EV$321.89B
P/B5.41
Shares Out2.48B
P/Sales4.38
Revenue$65.01B
EV/EBITDA11.30

Merck & Co Inc (MRK) — Earnings Call Transcripts

44 earnings call transcripts available.

Latest Transcript

Q4 2025 Earnings Call

16 speakers8,538 words52 segments
Read →